FDA officials: ‘New normal’ may include annual COVID vaccination

In a new editorial, top officials at the US Food and Drug Administration (FDA) outlined some of the key considerations for an annual COVID-19 vaccination strategy that could occur alongside seasonal influenza vaccination.

“Administering additional COVID-19 vaccine doses to appropriate individuals this fall around the time of the usual influenza vaccine campaign has the potential to protect susceptible individuals against hospitalization and death, and therefore will be a topic for FDA consideration,” Commissioner Robert Califf, Principal Deputy Commissioner Janet Woodcock, and Center for Biologics Evaluation and Research (CBER) Director Peter Marks, wrote in a JAMA Viewpoint article published 02 May 2022.